The role of prophylactic tamsulosin ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma.: A randomized double-blind study

被引：0
|
作者：
Carlson, T
Ciezki, J
Elshaikh, M
Khuntia, D
Reddy, C
Mahadevan, A
Angermeier, K
Ulchaker, J
Klein, E
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1021
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [31] PECS I block for postoperative analgesia in patients undergoing breast augmentation surgery: a randomized double-blind placebo-controlled study
    Desroches, Jean
    Roy, Maxim
    Belliveau, Marc
    Leblanc, Benoit
    Beaulieu, Pierre
    REVISTA BRASILEIRA DE ANESTESIOLOGIA, 2020, 70 (04): : 333 - 342
  • [32] SPARTAN, a phase 3 double-blind, randomized study of apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    Hadaschik, B. A.
    Small, E. J.
    Saad, F.
    Chowdhury, S.
    Graff, J. N.
    Olmos, D.
    Mainwaring, P. N.
    Uemura, H.
    Lopez-Gitlitz, A.
    Trudel, G. C.
    Espina, B. M.
    Shu, Y.
    Park, Y. C.
    Rackoff, W. R.
    Yu, M. K.
    Smith, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 43 - 43
  • [33] Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
    Chi, Kim N.
    Chowdhury, Simon
    Bjartell, Anders
    Byung Ha Chung
    Gomes, Andrea J. Pereira de Santana
    Given, Robert
    Juarez, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Brookman-May, Sabine
    Mundle, Suneel D.
    McCarthy, Sharon A.
    Larsen, Julie S.
    Sun, Weili
    Bevans, Katherine B.
    Zhang, Ke
    Bandyopadhyay, Nibedita
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) : 2294 - +
  • [34] Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer
    T Kylmälä
    T Taube
    TLJ Tammela
    L Risteli
    J Risteli
    I Elomaa
    British Journal of Cancer, 1997, 76 : 939 - 942
  • [35] Prevention of postoperative nausea and vomiting with a small dose of propofol combined with dexamethasone 4 mg or dexamethasone 8 mg in patients undergoing middle ear surgery A prospective, randomized, double-blind study
    Arslan, M.
    Demir, M. E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (06): : 332 - 336
  • [36] CANTATA: Randomized, international, double-blind study of CB-839 plus cabozantinib versus cabozantinib plus placebo in patients with metastatic renal cell carcinoma.
    Tannir, Nizar M.
    Agarwal, Neeraj
    Dawson, Nancy Ann
    Motzer, Robert J.
    Jacobs, Carmel Maree
    Choueiri, Toni K.
    Hrom, John Stewart
    Geynisman, Daniel M.
    Davis, Nancy B.
    Figlin, Robert A.
    O'Keeffe, Mary Kathleen
    Parikh, Jigarkumar R.
    Vaena, Daniel A.
    Liu, Ping-Yu
    O'Keeffe, Bridget
    Xuan Tran
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [37] RENAVIV: A randomized phase III, double-blind, placebo-controlled study of pazopanib with or without abexinostat in patients with locally advanced or metastatic renal cell carcinoma.
    Aggarwal, Rahul Raj
    Thomas, Scott
    Hauke, Ralph J.
    Nordquist, Luke T.
    Munster, Pamela N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [38] A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer
    Hille, A
    Schmidberger, H
    Hermann, RM
    Christiansen, H
    Saile, B
    Pradier, O
    Hess, CF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1488 - 1493
  • [39] Quality of Life After Sipuleucel-T Therapy: Results From a Randomized, Double-blind Study in Patients With Androgen-dependent Prostate Cancer
    Beer, Tomasz M.
    Schellhammer, Paul F.
    Corman, John M.
    Glode, L. Michael
    Hall, Simon J.
    Whitmore, James B.
    Frohlich, Mark W.
    Penson, David F.
    UROLOGY, 2013, 82 (02) : 410 - 415
  • [40] A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer
    Horti, Jozsef
    Widmark, Anders
    Stenzl, Arnulf
    Federico, Miriam H.
    Abratt, Raymond P.
    Sanders, Nick
    Pover, Gillian M.
    Bodrogi, Istvan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (02) : 175 - 180
12345